Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Grover

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogsG J Grover
Cardiovascular Research|September 1, 1993
An explanation for the reported observation that ATP dependent potassium channel openers fail to mimic preconditioningG J Grover
Cardiovascular Research|January 1, 1996
Mechanisms of action of various ATP-sensitive potassium channel openersG J Grover
EXS|January 1, 1996
The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the futureG J Grover
Journal of Cardiovascular Pharmacology|January 1, 1994
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemiaG J Grover
Canadian Journal of Physiology and Pharmacology|April 1, 1997
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusionG J Grover
Cardiovascular Research|June 1, 1994
Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemiaG J Grover
Journal of Molecular and Cellular Cardiology|April 11, 2000
ATP-Sensitive potassium channels: a review of their cardioprotective pharmacologyG J Grover, K D Garlid
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activationG J Grover, P G Sleph
Infection and Immunity|April 1, 1982
Effect of splenic sequestration of erythrocytes on splenic clearance function and susceptibility to septic peritonitisG J Grover, D J Loegering
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogsG J Grover
Cardiovascular Research|September 1, 1993
An explanation for the reported observation that ATP dependent potassium channel openers fail to mimic preconditioningG J Grover
Cardiovascular Research|January 1, 1996
Mechanisms of action of various ATP-sensitive potassium channel openersG J Grover
EXS|January 1, 1996
The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the futureG J Grover
Journal of Cardiovascular Pharmacology|January 1, 1994
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemiaG J Grover
Canadian Journal of Physiology and Pharmacology|April 1, 1997
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusionG J Grover
Cardiovascular Research|June 1, 1994
Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemiaG J Grover
Journal of Molecular and Cellular Cardiology|April 11, 2000
ATP-Sensitive potassium channels: a review of their cardioprotective pharmacologyG J Grover, K D Garlid
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activationG J Grover, P G Sleph
Infection and Immunity|April 1, 1982
Effect of splenic sequestration of erythrocytes on splenic clearance function and susceptibility to septic peritonitisG J Grover, D J Loegering
Pageof 14